Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01253343
Other study ID # 2010-0892
Secondary ID
Status Completed
Phase N/A
First received November 1, 2010
Last updated May 23, 2013
Start date September 2011
Est. completion date November 2012

Study information

Verified date May 2013
Source Children's Hospital Medical Center, Cincinnati
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

Violence and aggression on pediatric psychiatry units has led to staff and patient injuries and even deaths around the country. In an effort to improve safety, the investigators have developed a method (with the Brief Rating of Child and Adolescent Aggression) of identifying children and adolescents at a higher risk for aggression and violence on the units. In order to improve this prediction, the investigators plan to study salivary hormones in low risk children and high risk children. The salivary hormones to be studied include cortisol, testosterone, and dehydroepiandrosterone sulfate (DHEAS). The investigators expect to improve the investigators current ability to predict the severity and type of pediatric aggression and violence on the inpatient units by combining information from the Brief Rating of Child and Adolescent Aggression (BRACHA), the Predatory-Affective Aggression Scale (Vitiello et al., 1990), and salivary hormones.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date November 2012
Est. primary completion date November 2012
Accepts healthy volunteers No
Gender Male
Age group 7 Years to 9 Years
Eligibility Inclusion Criteria:

1. Prepubescent males (per parent report), African American or Caucasian, between 7 and 9 years old

2. Ability of the subject to provide assent

3. Ability of the guardian to give parental permission

4. Completion of the BRACHA questionnaire

5. Completion of the Predatory-Affective Aggression Scale (PAAS)

Exclusion Criteria:

1. Viral or bacterial infection or treatment with antibiotics within two weeks of screening

2. Recent surgery (within 8 weeks of screening)

3. Bleeding gums (within 8 weeks of screening)

4. Currently detained in a juvenile detention

5. Currently taking medications such as antipsychotic medications (besides Aripiprazole), steroids and beta adrenergic agonists that affect hormones

6. If it is the investigator's clinical judgment that the subject should be excluded if it is in the subject's best interest or due to any other factor that may interfere with study results

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Cincinnati Childrens Hospital Cincinnati Ohio

Sponsors (1)

Lead Sponsor Collaborator
Children's Hospital Medical Center, Cincinnati

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score We collected three saliva samples from each participant over a 24-hour period on one of the initial three hospital days to determine the peripheral concentrations of cortisol, dehydroepiandrosterone (DHEA), and testosterone. We then compared these levels with the participants BRACHA score. We wanted to determine if hormone concentrations could improve the BRACHA's accuracy of predicting pediatric aggression during psychiatric hospitalization. Collected on one or two days No
Primary Salivary Hormone Correlation With Brief Rating of Aggression by Children and Adolescent (BRACHA) Score. We collected three saliva samples from each participant over a 24-hour period on one of the initial three hospital days to determine the peripheral concentrations of cortisol, dehydroepiandrosterone (DHEA), and testosterone. We then compared these levels with the participants BRACHA score. We wanted to determine if hormone concentrations could improve the BRACHA's accuracy of predicting pediatric aggression during psychiatric hospitalization. Collected on one or two days No